Showing results (251-260 of 513) with videos related to

Sort By:
Pageof 52
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 11, 2011
Association of oral mucositis with quality of life and symptom clusters in patients with solid tumors receiving chemotherapyJin Won Kim, Yongjun Cha, Su-Jung Kim, et al.
Cancer Research and Treatment|January 9, 2010
A case of desmoplastic small round cell tumor diagnosed in a young female patientJi-Won Kim, Jin Hyun Park, Hyeon Jin Cho, et al.
Scientific Reports|August 9, 2020
Metabolic radiogenomics in lung cancer: associations between FDG PET image features and oncogenic signaling pathway alterationsGahyun Kim, Jinho Kim, Hongui Cha, et al.
Cancer Research and Treatment|January 24, 2013
Definitive Radiotherapy versus Postoperative Radiotherapy for Tonsil CancerTae Ryool Koo, Hong-Gyun Wu, J Hun Hah, et al.
JAMA Network Open|March 17, 2023
Trends in Survival Rates of Non-Small Cell Lung Cancer With Use of Molecular Testing and Targeted Therapy in Korea, 2010-2020Sang Ah Chi, Hyeyeon Yu, Yoon-La Choi, et al.
Cancer|November 17, 2011
Comparative analyses of overall survival in patients with anaplastic lymphoma kinase-positive and matched wild-type advanced nonsmall cell lung cancerJune Koo Lee, Heae Surng Park, Dong-Wan Kim, et al.
Asia-Pacific Journal of Clinical Oncology|March 1, 2014
Sunitinib in metastatic renal cell carcinoma: an ethnic Asian subpopulation analysis for safety and efficacySe-Hoon Lee, Yung-Jue Bang, Paul Mainwaring, et al.
Cancer Research|August 30, 2022
High-Resolution Profiling of Lung Adenocarcinoma Identifies Expression Subtypes with Specific Biomarkers and Clinically Relevant VulnerabilitiesWhijae Roh, Yifat Geffen, Hongui Cha, et al.
JTO Clinical and Research Reports|September 22, 2025
First-line Selpercatinib or Chemotherapy and Pembrolizumab in Patients From East Asia With <i>RET</i> Fusion-Positive NSCLC: A LIBRETTO-431 Subgroup AnalysisKoichi Goto, Herbert H Loong, Caicun Zhou, et al.
Immune Network|January 11, 2021
Immunological Characteristics of Hyperprogressive Disease in Patients with Non-small Cell Lung Cancer Treated with Anti-PD-1/PD-L1 AbsKyung Hwan Kim, Joon Young Hur, Jiae Koh, et al.
Pageof 52